AstraZeneca preps COVID-19 vaccine for FDA filing armed with 79% efficacy stat esagonowsky Mon, 03/22/2021 – 08:39

Roche’s Tecentriq is the first I-O drug to claim a post-surgery win in lung cancer. But will doctors […]

Stroke patients treated via a mobile stroke unit (MSU) received clot-busting medications faster and more often – and […]

The Research Group on Synthetic Biology for Biomedical Applications at Pompeu Fabra University in Barcelona, Spain, has designed […]

Recurrent pericarditis is an autoinflammatory cardiovascular disease

UK-based charity conducted a review of GP access between April 2019 and December 2020

Kyprolis plus lenalidomide and dexamethasone approved as a second-line treatment

Tecentriq is approved in five lung cancer indications currently

Bayer, Roche, Novo Nordisk, J&J, Novartis and Gilead among the Sweet 16 advancing in #FierceMadness DTC ad tourney […]

A new antibiotic compound clears infection of multi-drug resistant gonorrhea in mice in a single oral dose, according […]